Statement: Patients must be over the age of 18 and have a life expectancy over 6 months to participate in the primary trial.
Primary_evidence: Inclusion Criteria:   To be included in this study, you must meet the following criteria:   Adenocarcinoma of the breast confirmed by biopsy   Female Patients >18 years of age   Normal cardiac function   Ability to perform activities of daily living with minimal assistance   Chemotherapy naïve or have received prior chemotherapy > 5 years ago   Adequate bone marrow, liver and kidney function   Be informed of the investigational nature of this study   Sign an informed consent form   Sentinel lymph node and/or axillary dissection prior to enrollment Exclusion Criteria:   You cannot participate in this study if any of the following apply to you:   Life expectancy of < than 6 months   History of significant heart disease   Prior chemotherapy or hormonal therapy   Concurrent Trastuzumab therapy   History of significant psychiatric disorders   History of active uncontrolled infection   Please note: There are additional inclusion/exclusion criteria. The study center will determine if you meet all of the criteria. If you do not qualify for the trial, study personnel will explain the reasons. If you do qualify, study personnel will explain the trial in detail and answer any questions you may have.